PureTech Health PLC (PRTC) has a current Price-to-Book (P/B) ratio of 10.96. Compared to its 3-year average P/B ratio of 5.65, the current P/B ratio is approximately 93.88% higher. Relative to its 5-year average P/B ratio of 4.04, the current P/B ratio is about 171.22% higher. PureTech Health PLC (PRTC) has a Forward Free Cash Flow (FCF) yield of approximately -24.75%. Compared to its 3-year average FCF yield of -23.31%, the current FCF yield is approximately 6.18% lower. Relative to its 5-year average FCF yield of -21.01%, the current FCF yield is about 17.81% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for PRTC competitors is 0.00, providing a benchmark for relative valuation. PureTech Health PLC Corp (PRTC.O) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of PRTC increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of PRTC in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is PRTC currently overvalued or undervalued?

What is PureTech Health PLC (PRTC) fair value?

PRTC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of PureTech Health PLC (PRTC) is between NaN to NaN according to relative valuation method.

How does PRTC's valuation metrics compare to the industry average?

The average P/S ratio for PRTC's competitors is 0.00, providing a benchmark for relative valuation. PureTech Health PLC Corp (PRTC) exhibits a P/S ratio of 0.00, which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

What is the current P/B ratio for PureTech Health PLC (PRTC) as of Mar 02 2026?

As of Mar 02 2026, PureTech Health PLC (PRTC) has a P/B ratio of 10.96. This indicates that the market values PRTC at 10.96 times its book value.

What is the current FCF Yield for PureTech Health PLC (PRTC) as of Mar 02 2026?

As of Mar 02 2026, PureTech Health PLC (PRTC) has a FCF Yield of -24.75%. This means that for every dollar of PureTech Health PLC's market capitalization, the company generates -24.75 cents in free cash flow.

What is the current Forward P/E ratio for PureTech Health PLC (PRTC) as of Mar 02 2026?

As of Mar 02 2026, PureTech Health PLC (PRTC) has a Forward P/E ratio of -5.62. This means the market is willing to pay $-5.62 for every dollar of PureTech Health PLC's expected earnings over the next 12 months.

What is the current Forward P/S ratio for PureTech Health PLC (PRTC) as of Mar 02 2026?

As of Mar 02 2026, PureTech Health PLC (PRTC) has a Forward P/S ratio of 0.00. This means the market is valuing PRTC at $0.00 for every dollar of expected revenue over the next 12 months.

PRTC Valuation